US 7674779
RNAi modulation of MLL-AF4 and uses thereof
granted A61PA61P35/00A61P35/02
Quick answer
US patent 7674779 (RNAi modulation of MLL-AF4 and uses thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P43/00